GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shine-On BioMedical Co Ltd (ROCO:6926) » Definitions » EV-to-FCF

Shine-On BioMedical Co (ROCO:6926) EV-to-FCF : -21.29 (As of Apr. 08, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Shine-On BioMedical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shine-On BioMedical Co's Enterprise Value is NT$1,946.94 Mil. Shine-On BioMedical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-91.45 Mil. Therefore, Shine-On BioMedical Co's EV-to-FCF for today is -21.29.

The historical rank and industry rank for Shine-On BioMedical Co's EV-to-FCF or its related term are showing as below:

ROCO:6926' s EV-to-FCF Range Over the Past 10 Years
Min: -80.54   Med: -77.13   Max: -24.5
Current: -24.5

During the past 6 years, the highest EV-to-FCF of Shine-On BioMedical Co was -24.50. The lowest was -80.54. And the median was -77.13.

ROCO:6926's EV-to-FCF is ranked worse than
100% of 460 companies
in the Biotechnology industry
Industry Median: 2.335 vs ROCO:6926: -24.50

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-08), Shine-On BioMedical Co's stock price is NT$60.00. Shine-On BioMedical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.390. Therefore, Shine-On BioMedical Co's PE Ratio (TTM) for today is At Loss.


Shine-On BioMedical Co EV-to-FCF Historical Data

The historical data trend for Shine-On BioMedical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shine-On BioMedical Co EV-to-FCF Chart

Shine-On BioMedical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial - - -79.92 -74.28 -25.55

Shine-On BioMedical Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only -79.92 - -74.28 - -25.55

Competitive Comparison of Shine-On BioMedical Co's EV-to-FCF

For the Biotechnology subindustry, Shine-On BioMedical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shine-On BioMedical Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shine-On BioMedical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shine-On BioMedical Co's EV-to-FCF falls into.


;
;

Shine-On BioMedical Co EV-to-FCF Calculation

Shine-On BioMedical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1946.942/-91.448
=-21.29

Shine-On BioMedical Co's current Enterprise Value is NT$1,946.94 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shine-On BioMedical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-91.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shine-On BioMedical Co  (ROCO:6926) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shine-On BioMedical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=60.00/-2.390
=At Loss

Shine-On BioMedical Co's share price for today is NT$60.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shine-On BioMedical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.390.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shine-On BioMedical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shine-On BioMedical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shine-On BioMedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 633, Section 2, Taiwan Avenue, Unit 6, 5th Floor, Xitun District, Taichung, TWN
Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with the most effective cancer treatment options.

Shine-On BioMedical Co Headlines

No Headlines